Original Articles

You have full text access to this OnlineOpen article

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis

  1. John Moore1,*,
  2. Peter Brooks2,
  3. Sam Milliken1,
  4. Jim Biggs1,
  5. David Ma1,
  6. Malcolm Handel1,
  7. Paul Cannell3,
  8. Rob Will3,
  9. Simon Rule4,
  10. David Joske4,
  11. Bob Langlands4,
  12. Kerry Taylor5,
  13. Joe O'Callaghan5,
  14. Jeff Szer6,
  15. Ian Wicks6,
  16. Geoff McColl6,
  17. Frances Passeullo7,
  18. John Snowden8

Article first published online: 27 SEP 2002

DOI: 10.1002/art.10495

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 9, pages 2301–2309, September 2002

Additional Information

How to Cite

Moore, J., Brooks, P., Milliken, S., Biggs, J., Ma, D., Handel, M., Cannell, P., Will, R., Rule, S., Joske, D., Langlands, B., Taylor, K., O'Callaghan, J., Szer, J., Wicks, I., McColl, G., Passeullo, F. and Snowden, J. (2002), A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis & Rheumatism, 46: 2301–2309. doi: 10.1002/art.10495

Author Information

  1. 1

    St. Vincents Hospital, Sydney, Australia

  2. 2

    University of Queensland, Queensland, Australia

  3. 3

    Royal Perth Hospital, Perth, Australia

  4. 4

    Sir Charles Gardiner Hospital, Perth, Australia

  5. 5

    Mater Hospital, Brisbane, Australia

  6. 6

    Royal Melbourne Hospital, Melbourne, Australia

  7. 7

    Amgen, Melbourne, Australia

  8. 8

    Leicester Royal Infirmary, Leicester, UK

*Haematology Department, St. Vincents Hospital, Victoria Road, Darlinghurst, NSW, Australia

Publication History

  1. Issue published online: 27 SEP 2002
  2. Article first published online: 27 SEP 2002
  3. Manuscript Accepted: 17 MAY 2002
  4. Manuscript Received: 27 NOV 2001

Funded by

  • The National Health and Medical Research Council of Australia
  • Amgen, Australia

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (104K)

REFERENCES

  • 1
    Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993; 19: 123–51.
  • 2
    Van Bekkum DW. New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation. Clin Immunol Immunopathol 1998; 89: 1–10.
  • 3
    Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune diseases. Br J Haematol 1997; 99: 9–22.
    Direct Link:
  • 4
    Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, et al. Autologous haematopoietic stem cell transplants for autoimmune disease: feasibility and transplant-related mortality. Bone Marrow Transplant 1999; 24: 729–34.
  • 5
    Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621–5.
  • 6
    Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643–5.
  • 7
    Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 1997; 40: 598–609.
    Direct Link:
  • 8
    Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999; 42: 2286–92.
    Direct Link:
  • 9
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 10
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45.
    Direct Link:
  • 11
    Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727–35.
    Direct Link:
  • 12
    Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22: 1035–41.
  • 13
    Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 1999; 42: 2281–5.
    Direct Link:
  • 14
    Verburg RJ, Kruize AA, van den Hoogen FHJ, Fibbe WE, Petersen EJ, Preijers F, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 2001; 44: 754–60.
    Direct Link:
  • 15
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253–9.
  • 16
    Maini R, St.Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999; 354: 1932–9.
  • 17
    Holmberg LA, Boeckh M, Hooper H, Leisenring W, Rowley S, Heimfeld S, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999; 94: 4029–35.
  • 18
    Van der Lubbe PA, Dijkmans BAC, Markusse HM, Nässander U, Breedveld FC. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum 1995; 38: 1097–106.
    Direct Link:
  • 19
    Edwards JCW, Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol 1998; 37: 126–30.
View Full Article (HTML) Get PDF (104K)